NEWS COMMENTARY

Stanford and Apple announce the results of their much-anticipated Apple Heart Study

Published:
March 20, 2019
Coverage:
Digital Transformation More...
Activities:
Research
13275 thumb square
by Nardev Ramanathan
Average importance

Not ideal, but promising – that's the key takeaway from the much-anticipated Apple Heart Study, whose main objective was to identify what proportion of its users with an irregular pulse were in fact suffering from atrial fibrillation (AF) as validated by subsequent electrocardiogram (ECG) patch monitoring. Around one-third of the participants who received irregular heartbeat notifications and followed through with ECG monitoring were accurately identified as suffering AF. While the device was good at identifying users who had AF, two-thirds of the cases it identified were false alerts. This creates unnecessary anxiety and activation of healthcare providers. More follow-up studies are likely; interested clients should monitor. 

For the original news article, click here .


Further Reading

Ketogenic nutrition breath sensor developer closes $2.5 million seed round

News Commentary | November 30, 2018

A ketogenic diet forces the body into a state of mild ketosis, where the body preferentially burns fat as a result of low carbohydrate intake. The state of ketosis can be measured based on the level of acetone in a person's breath. Keyto, a company that develops an app with a connected device that ... Not part of subscription

Senseonics becomes the third company to score a nonadjunctive labeling claim from the U.S. FDA for its continuous glucose monitor (CGM)

News Commentary | June 14, 2019

The nonadjunctive indication approval was given to Senseonics' Eversense 90‑day continuous glucose monitoring system (CGM). This allows its CGM device to be used as a replacement for finger pricks on a glucometer. The FDA approval closes the gap with competitors Dexcom and Abbott (both of which have... Not part of subscription

Zhejiang University School of Medicine validates that zinc supplementation has potential for preventing and managing diabetes

News Commentary | July 9, 2019

The group conducted a meta‑analysis of 32 studies that totaled 1,700 participants in 14 countries. Compared with control groups, subjects provided with zinc supplementation demonstrated a statistically significant reduction in fasting glucose, two‑hour postprandial glucose, and fasting insulin, ... To read more, click here.